Skip to main content
Published Online:https://doi.org/10.3928/00904481-20120110-08
First page image

  • 1.Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: summary report. Pediatrics. 2011; 128Suppl 5:S213–S256.

    MedlineGoogle Scholar
  • 2.Rodenburg J, Vissers MN, Wiegman A, et al.Statin treatment in children with familial hypercholesterolemia: the younger, the better. Circulation. 2007; 116(6):664–668.10.1161/CIRCULATIONAHA.106.671016

    Crossref MedlineGoogle Scholar
  • 3.Hopkins PN, Toth PP, Ballantyne CM, Rader DJNational Lipid Association Expert Panel on Familial Hypercholesterolemia. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011; 5(3S):S9–S17.10.1016/j.jacl.2011.03.452

    Crossref MedlineGoogle Scholar
  • 4.Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998; 338(23):1650–1656.10.1056/NEJM199806043382302

    Crossref MedlineGoogle Scholar
  • 5.Raitakari OT, Juonala M, Kähönen M, et al.Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003; 290(17):2277–2283.10.1001/jama.290.17.2277

    Crossref MedlineGoogle Scholar
  • 6.van der Graaf A, Kastelein JJ, Wiegman A. Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention. J Inherit Metab Dis. 2009; 32(6):699–705.10.1007/s10545-009-1165-1

    Crossref MedlineGoogle Scholar
  • 7.Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation. 2003; 107(11):1562–1566.10.1161/01.CIR.0000061521.15730.6E

    Crossref MedlineGoogle Scholar
  • 8.National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992; 89(3):495–501.

    Crossref MedlineGoogle Scholar
  • 9.Grossman DC, Moyer VA, Melnyk BM, Chou R, DeWitt TGUS Preventive Services Task Force. The anatomy of a US Preventive Services Task Force Recommendation: lipid screening for children and adolescents. Arch Pediatr Adolesc Med. 2011; 165(3):205–210.10.1001/archpediatrics.2010.299

    Crossref MedlineGoogle Scholar
  • 10.Daniels SR, Greer FRCommittee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008; 122(1):198–208.10.1542/peds.2008-1349

    Crossref MedlineGoogle Scholar
  • 11.Benlian P, De Gennes JL, Foubert L, Zhang H, Gagné SE, Hayden M. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med. 1996; 335(12):848–854.10.1056/NEJM199609193351203

    Crossref MedlineGoogle Scholar
  • 12.Kuvin JT, Karas RH. The effects of LDL reduction and HDL augmentation on physiologic and inflammatory markers. Curr Opin Cardiol. 2003; 18(4):295–300.10.1097/00001573-200307000-00009

    Crossref MedlineGoogle Scholar
  • 13.Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation. 2005; 112(22):3375–3383.10.1161/CIRCULATIONAHA.104.532499

    Crossref MedlineGoogle Scholar
  • 14.Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol. 2011; 8(4):222–232.10.1038/nrcardio.2010.222

    Crossref MedlineGoogle Scholar
  • 15.Ritchie SK, Murphy EC, Ice C, et al.Universal versus targeted blood cholesterol screening among youth: The CARDIAC project. Pediatrics. 2010; 126(2):260–265.10.1542/peds.2009-2546

    Crossref MedlineGoogle Scholar
  • 16.Fung MA, Frohlich JJ. Common problems in the management of hypertriglyceridemia. CMAJ. 2002; 167(11):1261–1266.

    MedlineGoogle Scholar
  • 17.Chatterjee C, Sparks DL. Hepatic lipase, high density lipoproteins, and hypertriglyceridemia. Am J Pathol. 2011; 178(4):1429–1333.10.1016/j.ajpath.2010.12.050

    Crossref MedlineGoogle Scholar
  • 18.Gaddi A, Cicero AF, Odoo FO, Poli AA, Paoletti R. Atherosclerosis and Metabolic Diseases Study Group. Practical guidelines for familial combined hyperlipidemia diagnosis: an update. Vasc Health Risk Manag. 2007; 3(6):877–886.

    MedlineGoogle Scholar
  • 19.Bruin T, Castro M, Dallinga-Thie G, Erkelens W. Familial Combined Hyperlipidemia — do we understand the pathophysiology and genetics? In: , Betteridge J, ed. Lipids: Current Perspectives. London: Martin Dunitz Ltd; 1996: 101–114.

    Google Scholar
  • 20.Kwiterovich PO. Recognition and management of dyslipidemia in children and adolescents. J Clin Endocrinol Metab. 2008; 93(11):4200–4209.10.1210/jc.2008-1270

    Crossref MedlineGoogle Scholar
  • 21.Glaser NS, Geller DH, Haqq A, Gitelman S, Malloy MLawson Wilkins Pediatric Endocrine Society Committee on Drugs and Therapeutics. Detecting and treating hyperlipidemia in children with type 1 diabetes mellitus: are standard guidelines applicable to this special population?Pediatr Diabetes. 2011; 12(4Pt2):442–459.10.1111/j.1399-5448.2010.00709.x.

    Crossref MedlineGoogle Scholar
  • 22.Maahs DM, Wadwa RP, Bishop F, Daniels SR, Rewers M, Klingensmith GJ. Dyslipidemia in youth with diabetes: to treat or not to treat?J Pediatr. 2008; 153(4):458–465.10.1016/j.jpeds.2008.05.062

    Crossref MedlineGoogle Scholar
  • 23.Goharkhay N, Tamayo EH, Yin H, Hankins GD, Saade GR, Longo M. Maternal hypercholesterolemia leads to activation of endogenous cholesterol synthesis in the offspring. Am J Obstet Gynecol. 2008; 199(3):273.e1–e6.10.1016/j.ajog.2008.06.064

    CrossrefGoogle Scholar
  • 24.Steiner MJ, Skinner AC, Perrin EM. Fasting Might Not Be Necessary Before Lipid Screening: A Nationally Representative Cross-sectional Study. Pediatrics. 2011.10.1542/peds.2011-0844

    CrossrefGoogle Scholar
  • 25.Gokee LaRose J, Tate DF, Gorin AA, Wing RR. Preventing weight gain in young adults: a randomized controlled pilot study. Am J Prev Med. 2010; 39(1):63–68.10.1016/j.amepre.2010.03.011

    Crossref MedlineGoogle Scholar
  • 26.van der Graaf A, Kastelein JJ, Wiegman A. Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention. J Inherit Metab Dis. 2009; 32(6):699–705.10.1007/s10545-009-1165-1

    Crossref MedlineGoogle Scholar
  • 27.Glueck CJ, Tsang RC, Fallat RW, Mellies M. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months. Pediatrics. 1977; 59(3):433–441.

    Crossref MedlineGoogle Scholar
  • 28.O’Gorman CS, Higgins MF, O’Neill MB. Systematic review and metaanalysis of statins for heterozygous familial hypercholesterolemia in children: evaluation of cholesterol changes and side effects. Pediatr Cardiol. 2009; 30(4):482–489.10.1007/s00246-008-9364-3

    Crossref MedlineGoogle Scholar
  • 29.de Jongh S, Lilien MR, op’t Roodt J, Stroes ES, Bakker HD, Kastelein JJ. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol. 2002; 40(12):2117–2121.10.1016/S0735-1097(02)02593-7

    Crossref MedlineGoogle Scholar

We use cookies on this site to enhance your user experience. For a complete overview of all the cookies used, please see our privacy policy.

×